Company intelligence / Profile preview
LitePharmTech
Seoul, Seoul Special City, South Koreapmc.ncbi.nlm.nih.gov ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
LitePharmTech develops a range of medical products including photosensitizers for photodynamic cancer therapy/diagnosis and antioxidant injections. Some pipeline programs are in preclinical stages; several marketed products exist for cancer treatment, infectious disease support, diabetes management, ophthalmology, and anti-aging[1][2][3][4][9].
- Therapeutic areas
- GastroenterologyOncologyInfectious DiseasesOphthalmology
- Modalities
- Small moleculePhotosensitizerBiologic
- Industry
- Biotech
02
Drug pipeline
10 assets9 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on LitePharmTech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LitePharmTech.